Savior Lifetec Market Cap ($191.21 Million)
Market Cap & Net Worth: Savior Lifetec (4167)
Savior Lifetec market cap. Savior Lifetec (TWO:4167) has a market capitalization of $191.21 Million (NT$6.07 Billion) as of November 5, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #16527 globally and #797 in its home market, demonstrating a -5.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Savior Lifetec's stock price NT$19.55 by its total outstanding shares 310444107 (310.44 Million). Also see 4167 cash flow metrics for how efficiently the company converts equity into cash flow.
Savior Lifetec Market Cap History (2015–2026)
Savior Lifetec market cap history from 2015 to 2026. Data shows change from $258.01 Million to $191.21 Million (-4.92% CAGR). Check Savior Lifetec stock price for real-time trading data and today's change.
Savior Lifetec Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Savior Lifetec's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Savior Lifetec to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.15x
Savior Lifetec's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.33x
Savior Lifetec's market cap is 0.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $250.61 Million | $1.53 Billion | -$207.70 Million | 0.16x | N/A |
| 2017 | $255.16 Million | $1.62 Billion | $22.27 Million | 0.16x | 11.46x |
| 2018 | $152.19 Million | $1.10 Billion | -$359.55 Million | 0.14x | N/A |
| 2019 | $200.75 Million | $1.32 Billion | -$44.05 Million | 0.15x | N/A |
| 2020 | $316.91 Million | $1.83 Billion | $250.94 Million | 0.17x | 1.26x |
| 2021 | $185.07 Million | $1.74 Billion | -$4.76 Million | 0.11x | N/A |
| 2022 | $240.30 Million | $1.27 Billion | $20.62 Million | 0.19x | 11.66x |
| 2023 | $218.77 Million | $1.05 Billion | $30.03 Million | 0.21x | 7.29x |
| 2024 | $199.53 Million | $1.22 Billion | $182.38 Million | 0.16x | 1.09x |
| 2025 | $179.96 Million | $1.20 Billion | $537.45 Million | 0.15x | 0.33x |
Competitor Companies of 4167 by Market Capitalization
Companies near Savior Lifetec in the global market cap rankings as of November 5, 2026. Also see balance sheet size of Savior Lifetec for a full breakdown of the balance sheet.
Key companies related to Savior Lifetec by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Savior Lifetec (2015–2026)
Market capitalization of Savior Lifetec from 2015 to today. Between 2015 and today, Savior Lifetec's market cap moved from $258.01 Million to $ 191.21 Million, with a yearly change of -4.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$191.21 Million | +6.25% |
| 2025 | NT$179.96 Million | -9.80% |
| 2024 | NT$199.53 Million | -8.80% |
| 2023 | NT$218.77 Million | -8.96% |
| 2022 | NT$240.30 Million | +29.84% |
| 2021 | NT$185.07 Million | -41.60% |
| 2020 | NT$316.91 Million | +57.86% |
| 2019 | NT$200.75 Million | +31.91% |
| 2018 | NT$152.19 Million | -40.36% |
| 2017 | NT$255.16 Million | +1.82% |
| 2016 | NT$250.61 Million | -2.87% |
| 2015 | NT$258.01 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Savior Lifetec was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $191.21 Million USD |
| MoneyControl | $191.21 Million USD |
| MarketWatch | $191.21 Million USD |
| marketcap.company | $191.21 Million USD |
| Reuters | $191.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Savior Lifetec
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more